Hutch News
Results per Page:
A Journey Through Our Genes: The Story of Prostate Cancer's Hidden Secrets
From the Darst research group, Public Health Sciences Division
RNA stability may play a role in prostate cancer
New research links mutations in RNA region that helps regulate protein production to progression and drug resistance
Navigating a cancer diagnosis while pregnant
Rare genetic mutation leads to cancer, treatment and vigilant screening for family
The cell’s two-pronged approach to mitigating genetic errors
From the Bradley Lab, Public Health Sciences and Basic Sciences Divisions
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Outwitting the foe: predicting evolved antibody escape in SARS-CoV-2
From the Bloom Lab (Basic Sciences Division)
Mutated skin stem cells self-correct to prevent cancer
New study helps explain why inherited cancer-driving mutations don’t always lead to cancer
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
New research uncovers how common genetic mutation drives cancer
Findings in Nature show that targeted therapy for mutated gene can slow or prevent tumor growth in many kinds of cancer
How a common cancer mutation actually drives cancer — and how to correct it
High-tech approach solves ‘real mystery’ in many cancers
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
The lung cancer blame game
The shame, blame and stigma surrounding this deadly disease affects everything from patient follow-through to research funding
Reawakening the X chromosome: New possible therapeutic targets for rare neurological disorder
Study points to potential reversal of rare childhood neurological disorder by reactivating silenced copy of the disease-linked gene
Common genetic disorder linked to increased death rate from cancer drug
Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
New technique reveals cells’ tiny engines unexpectedly shrug off DNA damage from toxic chemicals
A precise new technique reveals that our cells’ engines, mitochondria, unexpectedly shrug off DNA damage from toxic chemicals
Good News at Fred Hutch: Dr. Anne McTiernan named to HHS panel; Dr. Harlan Robins is co-PI on two projects
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements